Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

3.8K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.8K
RNA-seq03:21

RNA-seq

10.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent-child alienation, peer alienation, and sleep disturbance in Chinese college students: a longitudinal study of bidirectional relationships and gender differences.

BMC psychology·2026
Same author

Circulating M-MDSC Expansion During Therapy Associates With Treatment Response in Multiple Myeloma: A Longitudinal Observational Study.

Clinical and translational science·2026
Same author

A Novel Autologous Osteoperiosteal Composite for Osteochondral Regeneration.

The American journal of sports medicine·2026
Same author

Electroacupuncture Protects Against Post-MI Heart Failure Through Autonomic Regulation and α7nAChR Activation.

Cardiology research and practice·2026
Same author

Inhalable extracellular vesicle delivered IL-10 mRNA attenuates pulmonary hypertension in rats.

Journal of nanobiotechnology·2026
Same author

CAND1 drives intestinal ischemia/reperfusion injury via SCF<sup>FBXO6</sup>-PKM2-mediated mitochondrial fission and apoptosis.

Free radical biology & medicine·2026

Related Experiment Video

Updated: Nov 2, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.6K

Novel Non-coding RNA Analysis in Multiple Myeloma Identified Through High-Throughput Sequencing.

Minqiu Lu1,2, Yin Wu1, Wen Gao1

  • 1Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Frontiers in Genetics
|June 10, 2021
PubMed
Summary

Novel non-coding ribose nucleic acids (ncRNAs) show potential in multiple myeloma (MM). This study identified two new ncRNAs linked to MM oncogenes, offering new therapeutic targets for this blood cancer.

Keywords:
ceRNAmultiple myelomanon-coding RNAsoncogenesequencing

More Related Videos

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.0K

Related Experiment Videos

Last Updated: Nov 2, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.6K
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.2K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled plasma cell proliferation.
  • The role of non-coding RNAs (ncRNAs) in MM pathogenesis remains incompletely understood.
  • Identifying novel molecular targets is crucial for developing effective MM therapies.

Purpose of the Study:

  • To investigate the expression patterns and functional roles of novel ncRNAs in multiple myeloma.
  • To identify specific ncRNAs associated with MM oncogenes and their potential as therapeutic targets.
  • To construct a regulatory network involving ncRNAs, messenger RNAs (mRNAs), and microRNAs (miRNAs) in MM.

Main Methods:

  • Whole-transcriptome RNA sequencing (RNA-seq) was performed on plasma cells from MM patients.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate ncRNA expression.
  • Bioinformatic analyses, including deep RNA-seq, cis/trans targeting prediction, and network construction, were employed.

Main Results:

  • Significant differential expression of ncRNAs was observed in MM patients compared to controls.
  • Two novel long non-coding RNAs (lncRNAs), MSTRG.155519 and MSTRG.13132, were identified and linked to MM oncogenes CEACAM1 and FAM46C, respectively.
  • A comprehensive lncRNA-mRNA-miRNA regulatory network in MM was successfully constructed.

Conclusions:

  • Novel ncRNAs, including specific lncRNAs, are dysregulated in multiple myeloma and may play significant roles in its pathogenesis.
  • The identified ncRNAs, particularly MSTRG.155519 and MSTRG.13132, represent potential diagnostic biomarkers and therapeutic targets for MM.
  • Further investigation into the functional mechanisms of these ncRNAs could pave the way for novel ncRNA-targeted therapies in MM.